Predictors of subsequent relapse-independent progression after high-efficacy therapy in relapsing multiple sclerosis. Foschi M, Surcinelli A, Panzera I, Miserocchi L M, Balducci G, Mancinelli L, Ganino C, Graziano F, Lagonigro E, di Ioia M, et al. Front Immunol. 2026; 17:1935407. PMID: 42688020. Abstract CommentRecommendBookmarkWatch